Anebulo Pharmaceuticals Inc (ANEB) — Net Asset Quality Index
Anebulo Pharmaceuticals Inc (ANEB) has a Net Asset Quality Index of 84.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $9.42 Million minus total liabilities of $1.49 Million yields net assets of $7.94 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Anebulo Pharmaceuticals Inc debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Anebulo Pharmaceuticals Inc Net Asset Quality Index Over Time (2020–2025)
This chart shows how Anebulo Pharmaceuticals Inc's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the index stands at 84.2%, representing net assets of $7.94 Million against total assets of $9.42 Million USD. For live market cap and overall valuation, see ANEB market cap overview.
Annual Net Asset Quality Index for Anebulo Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Anebulo Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Anebulo Pharmaceuticals Inc net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.0% | $11.66 Million | $12.15 Million | $487.69K | ▲ +2.4 pp |
| 2024 | 93.6% | $3.81 Million | $4.07 Million | $260.58K | ▲ +2.8 pp |
| 2023 | 90.8% | $10.60 Million | $11.67 Million | $1.07 Million | ▼ -5.9 pp |
| 2022 | 96.7% | $15.07 Million | $15.58 Million | $512.53K | ▼ -2.2 pp |
| 2021 | 98.9% | $21.41 Million | $21.65 Million | $241.63K | ▲ +6.3 pp |
| 2020 | 92.6% | $2.80 Million | $3.03 Million | $223.87K | — |